Form 4: Fulgent Genetics Chief Scientific Officer Sells Shares to Cover Tax Obligations

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,373 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Summary

• Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, sold 1,373 shares of the company's common stock on December 3, 2024.
• The sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on February 28, 2022.
• The shares were sold at a weighted-average price of $19.4999, with individual transaction prices ranging from $19.46 to $19.58.
• Following the transaction, Gao beneficially owns 919,469 shares of Fulgent Genetics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for company executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The sale of 1,373 shares is a relatively small transaction compared to the total shares held by the executive (919,469 shares).
• Similar transactions are regularly reported by executives at comparable companies.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

Fulgent Genetics, Hanlin Gao, stock sale, insider trading, restricted stock units, tax obligations, FLGT